Cargando…

Stem Cell-Based Clinical Trials for Diabetes Mellitus

Since its introduction more than twenty years ago, intraportal allogeneic cadaveric islet transplantation has been shown to be a promising therapy for patients with Type I Diabetes (T1D). Despite its positive outcome, the impact of islet transplantation has been limited due to a number of confoundin...

Descripción completa

Detalles Bibliográficos
Autores principales: de Klerk, Eleonora, Hebrok, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953062/
https://www.ncbi.nlm.nih.gov/pubmed/33716982
http://dx.doi.org/10.3389/fendo.2021.631463